|
|
|
Volumn 21, Issue 7 Pt 2, 2001, Pages
|
|
A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
OFLOXACIN;
ADULT;
ARTICLE;
CANADA;
CLASSIFICATION;
CLINICAL PATHWAY;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ECONOMICS;
HOSPITALIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LENGTH OF STAY;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PNEUMONIA;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
ANTI-INFECTIVE AGENTS;
CANADA;
COMMUNITY-ACQUIRED INFECTIONS;
CRITICAL PATHWAYS;
HOSPITALIZATION;
HUMANS;
INJECTIONS, INTRAVENOUS;
LENGTH OF STAY;
OFLOXACIN;
PNEUMONIA;
QUALITY OF LIFE;
QUESTIONNAIRES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 0035409281
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (21)
|
|
References (0)
|
